Studies Now Enrolling

Curis is conducting clinical trials to evaluate the efficacy and safety of potential investigational drug in cancer. See all currently enrolling clinical trials for Curis investigational therapies in the U.S. on

Relapse/Refractory Lymphomas, Diffuse large B-cell Lymphoma (DLBCL), or High-grade B-cell Lymphoma (HGBL) - NTC01742988

Relapse/Refractory Non-Hodgkin Lymphomas including those with MYD88 alterations - NCT03328078